Hordenine

Hordenine

SCHEMBL36798

CN(C)CCc1ccc(O)cc1

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 4/20 0.67
TAAR1 Q96RJ0 4/20 0.61
ESR1 P03372 3/20 0.59
ESR2 Q92731 1/20 0.59
CA2 P00918 1/20 0.52
KDM4E B2RXH2 3/20 0.51
ALDH1A1 P00352 3/20 0.50
ADRA2A P08913 3/20 0.50
SLC6A2 P23975 3/20 0.50
HTR1A P08908 1/20 0.50
CYP2C19 P33261 1/20 0.50
HTR3A P46098 1/20 0.50
BACE1 P56817 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
TMEM97 Q5BJF2 1/20 0.50
SIGMAR1 Q99720 1/20 0.50
ADORA3 P0DMS8 2/20 0.48
TACR2 P21452 2/20 0.48
SLC6A4 P31645 2/20 0.48
SLC6A3 Q01959 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hordenine SCHEMBL19896488 1.00 HRH3 (0.67) HRH3TAAR1ESR1ESR2CA2
Hordenine SCHEMBL11147428 0.98 HRH3 (0.64) HRH3TAAR1ESR1ESR2CA2
Hordenine SCHEMBL2478680 0.98 HRH3 (0.64) HRH3TAAR1ESR1ESR2CA2
Hordenine SCHEMBL28644842 0.96 HRH3 (0.61) HRH3TAAR1ESR1ESR2CA2
Hordenine SCHEMBL18329336 0.90 HRH3 (0.55) HRH3TAAR1ESR1ESR2CA2
Hordenine SCHEMBL6338584 0.90 HRH3 (0.55) HRH3TAAR1ESR1ESR2CA2
SCHEMBL18762839 0.87 HRH3 (0.84) HRH3TAAR1ALDH1A1CYP2C19SIGMAR1
Hordenine SCHEMBL18329338 0.87 HRH3 (0.52) HRH3TAAR1ESR1ESR2CA2
SCHEMBL2475962 0.86 ESR1 (0.55) HRH3TAAR1ESR1ESR2CA2
SCHEMBL28508133 0.85 SIGMAR1 (0.62) HRH3ESR1ESR2CA2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1438 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4746864-A1 C5 KETONE COMPOSITIONS AND RELATED METHODS FOR TREATING METABOLIC DYSFUNCTION Keto Innovations, LLC (US) 2026-05-27 EP claimed
US-20260132413-A1 AROGENATE DEHYDROGENASE POLYNUCLEOTIDES, POLYPEPTIDES AND METHODS OF USING THE SAME WISCONSIN ALUMNI RES FOUNDATION (US) 2026-05-14 US claimed
EP-4514146-B1 A COMBINATION FOR USE IN THE PREPARATION OF A DRINKABLE FOAMING OR FOAMABLE LIQUID, A DEVICE AND A METHOD FOR PREPARING AND DISPENSING A DRINKABLE FOAMING OR FOAMABLE LIQUID BAR ON B V (BE) 2026-05-13 EP claimed
EP-4712954-A1 C5 KETONE COMPOSITIONS AND RELATED METHODS FOR THERAPEUTIC AND PERFORMANCE SUPPLEMENTATION Keto Innovations, LLC (US) 2026-03-25 EP claimed
US-20250268845-A1 BONE REGENERATION COMPOSITION INCLUDING HORDENINE AND USE THEREOF NEWPATHBIO INC. (KR) 2025-08-28 US claimed
US-20250243350-A1 RUBBER COMPOSITION AND PNEUMATIC TIRE TOYO TIRE CORPORATION (JP) 2025-07-31 US claimed
US-20250243345-A1 RUBBER COMPOSITION AND PNEUMATIC TIRE TOYO TIRE CORPORATION (JP) 2025-07-31 US claimed
WO-2025136556-A1 COMPOSITIONS AND METHODS FOR MINIMIZING EFFECTS OF ALCOHOL INTOXICATION SAFETY SHOT, INC. (US) 2025-06-26 WO claimed
WO-2025133198-A1 ANTI-GREY HAIR CARE COMPOSITIONS UNILEVER IP HOLDINGS B.V. (NL) 2025-06-26 WO claimed
CN-120081885-A Substituted phenyl glycoside compound and preparation method and application thereof 浙江大学 2025-06-03 CN claimed
EP-0885008-A1 THE REGULATION OF APPETITE, BODY WEIGHT AND ATHLETIC FUNCTION WITH MATERIALS DERIVED FROM CITRUS VARIETIES Jones, Dennis (US) 1998-12-23 EP claimed
WO-1998014200-A1 THE REGULATION OF APPETITE, BODY WEIGHT AND ATHLETIC FUNCTION WITH MATERIALS DERIVED FROM CITRUS VARIETIES JONES DENNIS (US) 1998-04-09 WO claimed
US-4929248-A CROSSLINKED WITH EPOXY RESIN KANEBO CO., LTD. (JP) 1990-05-29 US claimed
EP-0145323-B1 TOUGHENED EPOXY COMPOSITION LOCTITE CORPORATION (US) 1988-05-11 EP claimed
EP-0046270-B1 NOVEL DERIVATIVES OF BIO-AFFECTING PHENOLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM INTERx RESEARCH CORPORATION (US) 1986-05-21 EP claimed
EP-0145323-A2 Toughened epoxy composition LOCTITE CORPORATION (US) 1985-06-19 EP claimed
US-4435613-A Semiconductor packing composition for an undersea cable, a cable containing said substance and a method of manufacturing such a cable LES CABLES DE LYON (FR) 1984-03-06 US claimed
US-4340681-A Process for the manufacture of foamed or non-foamed compositions REUTER TECHNOLOGIE GMBH (DE) 1982-07-20 US claimed
EP-0046270-A1 Novel derivatives of bio-affecting phenolic compounds and pharmaceutical composition containing them INTERx RESEARCH CORPORATION (US) 1982-02-24 EP claimed
EP-0033542-A2 Thermoplastic molding composition, epoxide-vinyl ester resin composition and method for making same PHILLIPS PETROLEUM COMPANY (US) 1981-08-12 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132413-A1 AROGENATE DEHYDROGENASE POLYNUCLEOTIDES, POLYPEPTIDES AND METHODS OF USING THE SAME PNP, RNGTT, DPYD HRH3 4066/4885TAAR1 2815/4885ESR1 2632/4885
US-20250268845-A1 BONE REGENERATION COMPOSITION INCLUDING HORDENINE AND USE THEREOF SOST, BMP4, HCAR3 HRH3 57/4885TAAR1 2640/4885ESR1 3852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.